The interplay between cellular stress and immune response can be variable and sometimes
contradictory. The mechanisms by which stress-activated pathways regulate the …

Most efforts aimed at understanding the notable heterogeneity of outcomes in multiple
sclerosis (MS) have focused on disease-specific factors, such as symptoms at initial …

Multiple sclerosis (MS) is a chronic progressive disabling disease of the central nervous
system (CNS) characterized by demyelination and neuronal injury. Dyslipidemia is observed …

Multiple sclerosis (MS) is a chronic disease of the central nervous system characterized by
massive infiltration of immune cells, demyelination, and axonal loss. Active MS lesions …

The identification of progression in multiple sclerosis is typically retrospective. Given the
profound burden of progressive multiple sclerosis, and the recent development of effective …

Multiple Sclerosis (MS) is an inflammatory demyelinating disorder in which remyelination
failure contributes to persistent disability. Cholesterol is rate-limiting for myelin biogenesis in …

Background: Previous studies evidenced a link between metabolic dysregulation,
inflammation, and neurodegeneration in multiple sclerosis (MS). Objectives: To explore …

Multiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system that
leads to demyelination and neurodegeneration has been associated with various …

Multiple sclerosis (MS) is a chronic neurological disorder, often affecting young people.
Comorbid disorders such as depression, anxiety and hypertension are common and can …

Background There is a high level of interest in the potential role of diet among the MS
community. There is a limited level of evidence for a Mediterranean-style dietary pattern in …